A Saccharomyces cerevisiae strain unable to store neutral lipids is tolerant to oxidative stress induced by α-synuclein

Free Radical Biology and Medicine

Volumn 49, Issue 11, 2010, Pages 1755-1764

  Sere, Yves Y ^a   Regnacq, Matthieu ^a   Colas, Jenny ^a   Berges, Thierry ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

Synuclein; FASN; Free radicals; GSH; Lipid droplets; Neutral lipids; Oxidative stress; Parkinson disease; Saccharomyces cerevisiae; Squalene

Indexed keywords

ALPHA SYNUCLEIN; ESTER DERIVATIVE; FAT DROPLET; FATTY ACID SYNTHASE; LIPID; TRIACYLGLYCEROL;

ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FUNGAL STRAIN; GENE; GENE MUTATION; MAMMAL CELL; NERVE CELL LESION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; SNCA GENE; WILD TYPE;

ADAPTATION, BIOLOGICAL; ALPHA-SYNUCLEIN; DRUG RESISTANCE; ENZYME ACTIVATION; FATTY ACID SYNTHETASE COMPLEX; GLUTATHIONE; LIPID METABOLISM; LIPID METABOLISM DISORDERS; MODELS, THEORETICAL; ORGANISMS, GENETICALLY MODIFIED; OXIDATION-REDUCTION; OXIDATIVE STRESS; SACCHAROMYCES CEREVISIAE; SQUALENE;

MAMMALIA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES;

EID: 78049386083     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.09.007     Document Type: Article

References (55)

1. Jakes R., Spillantini M.G., Goedert M. Identification of 2 distinct synucleins from human. FEBS Lett. 1994, 345:27-32.
2. Norris E.H., Giasson B.I., Lee V.M.Y. alpha-Synuclein: normal function and role in neurodegenerative diseases. Curr. Top. Dev. Biol. 2004, 60:17-54.
3. Trojanowski J.Q., Goedert M., Iwatsubo T., Lee V.M.Y. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ. 1998, 5:832-837.
4. Iseki E., Marui W., Kosaka K., Akiyama H., Ueda K., Iwatsubo T. Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci. Lett. 1998, 258:81-84.
5. Lippa C.F., Schmidt M.L., Lee V.M.Y., Trojanowski J.Q. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann. Neurol. 1999, 45:353-357.
6. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 1998, 251:205-208.
7. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 1998, 18:106-108.
8. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., DiIorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
9. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841-841.
10. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., Destee A. alpha-Synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004, 364:1167-1169.
11. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Llorens V., Tortosa E.G., del Ser T., Munoz D.G., de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 2004, 55:164-173.
12. Marsh J.L., Thompson L.M. Drosophila in the study of neurodegenerative disease. Neuron 2006, 52:169-178.
13. Cao P.X., Yuan Y.Y., Pehek E.A., Moise A.R., Huang Y., Palczewski K., Feng Z.Y. alpha-Synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans. PLoS ONE 2010, 5:e9312.
14. Nuber S., Franck T., Wolburg H., Schumann U., Casadei N., Fischer K., Calaminus C., Pichler B.J., Chanarat S., Teismann P., Schulz J.B., Luft A.R., Tomiuk J., Wilbertz J., Bornemann A., Kruger R., Riess O. Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice. Neurogenetics 2010, 11:107-120.
15. Sharma N., Brandis K.A., Herrera S.K., Johnson B.E., Vaidya T., Shrestha R., DebBurman S.K. alpha-Synuclein budding yeast model-toxicity enhanced by impaired proteasome and oxidative stress. J. Mol. Neurosci. 2006, 28:161-178.
16. Outeiro T.F., Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 2003, 302:1772-1775.
17. Dixon C., Mathias N., Zweig R.M., Davis D.A., Gross D.S. alpha-Synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics 2005, 170:47-59.
18. Zabrocki P., Pellens K., Vanhelmont T., Vandebroek T., Griffioen G., Wera S., Van Leuven F., Winderickx J. Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast. FEBS J. 2005, 272:1386-1400.
19. Khurana V., Lindquist S. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast?. Nat. Rev. Neurosci. 2010, 11:436-449.
20. Willingham S., Outeiro T.F., DeVit M.J., Lindquist S.L., Muchowski P.J. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 2003, 302:1769-1772.
21. Yeger-Lotem E., Riva L., Su L.J., Gitler A.D., Cashikar A.G., King O.D., Auluck P.K., Geddie M.L., Valastyan J.S., Karger D.R., Lindquist S., Fraenkel E. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity. Nat. Genet. 2009, 41:316-323.
22. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K.N., Xu K.X., Strathearn K.E., Liu F., Cao S.S., Caldwell K.A., Caldwell G.A., Marsischky G., Kolodner R.D., LaBaer J., Rochet J.C., Bonini N.M., Lindquist S. alpha-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006, 313:324-328.
23. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., Caldwell K.A., Caldwell G.A., Cooper A.A., Rochet J.C., Lindquist S. alpha-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 2009, 41:308-315.
24. Gaspar M.L., Jesch S.A., Viswanatha R., Antosh A.L., Brown W.J., Kohlwein S.D., Henry S.A. A block in endoplasmic reticulum-to-Golgi trafficking inhibits phospholipid synthesis and induces neutral lipid accumulation. J. Biol. Chem. 2008, 283:25735-25751.
25. Sandager L., Gustavsson M.H., Stahl U., Dahlqvist A., Wiberg E., Banas A., Lenman M., Ronne H., Stymne S. Storage lipid synthesis is non-essential in yeast. J. Biol. Chem. 2002, 277:6478-6482.
26. Garbarino J., Padamsee M., Wilcox L., Oelkers P.M., D'Ambrosio D., Ruggles K.V., Ramsey N., Jabado O., Turkish A., Sturley S.L. Sterol and diacylglycerol acyltransferase deficiency triggers fatty acid-mediated cell death. J. Biol. Chem. 2009, 284:30994-31005.
27. Petschnigg J., Wolinski H., Kolb D., Zellnig G., Kurat C.F., Natter K., Kohlwein S.D. Good fat, essential cellular requirements for triacylglycerol synthesis to maintain membrane homeostasis in yeast. J. Biol. Chem. 2009, 284:30981-30993.
28. Zhang Q., Chieu H.K., Low C.P., Zhang S.C., Heng C.K., Yang H.Y. Schizosaccharomyces pombe cells deficient in triacylglycerols synthesis undergo apoptosis upon entry into the stationary phase. J. Biol. Chem. 2003, 278:47145-47155.
29. Listenberger L.L., Han X.L., Lewis S.E., Cases S., Farese R.V., Ory D.S., Schaffer J.E. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 2003, 100:3077-3082.
30. Circu M.L., Aw T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48:749-762.
31. Xu J., Kao S.Y., Lee F.J.S., Song W.H., Jin L.W., Yankner B.A. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 2002, 8:600-606.
32. Flower T.R., Chesnokova L.S., Froelich C.A., Dixon C., Witt S.N. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J. Mol. Biol. 2005, 351:1081-1100.
33. Kirkland R., Franklin J. Evidence for redox regulation of cytochrome c release during programmed neuronal death: antioxidant effects of protein synthesis and caspase inhibition. J. Neurosci. 2001, 21:1949.
34. Bearden J. Quantitation of submicrogram quantities of protein by an improved protein-dye binding assay. Biochim. Biophys. Acta Protein Struct. 1978, 533:525-529.
35. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
36. Froissard M., D'Andrea S., Boulard C., Chardot T. Heterologous expression of AtClo1, a plant oil body protein, induces lipid accumulation in yeast. FEMS Yeast Res. 2009, 9:428-438.
37. Desfougeres T., Ferreira T., Berges T., Regnacq M. SFH2 regulates fatty acid synthase activity in the yeast Saccharomyces cerevisiae and is critical to prevent saturated fatty acid accumulation in response to haem and oleic acid depletion. Biochem. J. 2008, 409:299-309.
38. Rahman I., Kode A., Biswas S. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat. Protoc. 2007, 1:3159-3165.
39. Wheals A.E. Size control models of Saccharomyces cerevisiae cell proliferation. Mol. Cell. Biol. 1982, 2:361-368.
40. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 2001, 30:1191-1212.
41. Nomura S., Omura S., Hata T., Horiuchi T. The action mechanism of cerulenin. I. Effect of cerulenin on sterol and fatty acid biosynthesis in yeast. J. Biochem. 1972, 71:783-796.
42. Lee J., Dawes I.W., Roe J.H. Adaptive response of Schizosaccharomyces pombe to hydrogen peroxide and menadione. Microbiology 1995, 141:3127-3132.
43. Kelley R., Ideker T. Genome-wide fitness and expression profiling implicate Mga2 in adaptation to hydrogen peroxide. PLoS Genet. 2009, 5.
44. Sorger D., Athenstaedt K., Hrastnik C., Daum G. A yeast strain lacking lipid particles bears a defect in ergosterol formation. J. Biol. Chem. 2004, 279:31190-31196.
45. 2 in Saccharomyces cerevisiae. J. Biol. Chem. 2004, 279:6501-6506.
46. 2 in Saccharomyces cerevisiae. Free Radic. Biol. Med. 2009, 46:289-298.
47. Murphy D., Rueter S., Trojanowski J., Lee V. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 2000, 20:3214.
48. Menendez J.A., Vazquez-Martin A., Ortega F.J., Fernandez-Real J.M. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin. Chem. 2009, 55:425-438.
49. Menendez J.A., Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 2007, 7:763-777.
50. Ng C.H., Tan S.X., Perrone G.G., Thorpe G.W., Higgins V.J., Dawes I.W. Adaptation to hydrogen peroxide in Saccharomyces cerevisiae: the role of NADPH-generating systems and the SKN7 transcription factor. Free Radic. Biol. Med. 2008, 44:1131-1145.
51. Chen S., He Q., Greenberg M.L. Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth. Mol. Microbiol. 2008, 68:1061-1072.
52. Li J., Romestaing C., Han X., Li Y., Hao X., Wu Y., Sun C., Liu X., Jefferson L.S., Xiong J., Lanoue K.F., Chang Z., Lynch C.J., Wang H., Shi Y. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab. 2010, 12:154-165.
53. Das B., Antoon R., Tsuchida R., Lotfi S., Morozova O., Farhat W., Malkin D., Koren G., Yeger H., Baruchel S. Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. Neoplasia 2008, 10:1105-1153.
54. Warleta F., Campos M., Allouche Y., Sanchez-Quesada C., Ruiz-Mora J., Beltran G., Gaforio J.J. Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells. Food Chem. Toxicol. 2010, 48:1092-1100.
55. Kohno Y., Egawa Y., Itoh S., Nagaoka S., Takahashi M., Mukai K. Kinetic study of quenching reaction of singlet oxygen and scavenging reaction of free radical by squalene in n-butanol. Biochim. Biophys. Acta Lipids Lipid Metab. 1995, 1256:52-56.